Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy
1 clinical trials · Condition
◉ Watch Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy
| Record | Firm | Date |
|---|---|---|
| ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer (NCT00929162) | AstraZeneca | 2009-06-01 |
Track Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy automatically
Every clearance here is in the API, with alerts when new ones post.